Publications
-
High proportions of regulatory B and T cells are associated with decreased cellular responses to
Citation: Weinberg A, Muresan P, Fenton T, Richardson K, Dominguez T, Bloom A, Petzold E, Anthony P, Cunningham CK, Spector SA, Nachman S, Siberry GK, Handelsman E, Flynn PM; IMPAACT P1088 study team. High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088). Hum Vaccin Immunother. 2013 May;9(5):957-68. doi: 10.4161/hv.23774. Epub 2013 Jan 31. PMID: 23370281; PMCID: PMC3899162
Date: 05/01/2013
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naïve
Citation: Stein JH, Brown, TT, Ribaudo, HJ, Chen, Y , Yan M, Lauer-Brodell, E, McComsey, GA, Dubé, MP, Hodis, HN, Currier, JS. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naïve individuals with HIV infection. AIDS. 2013 Mar 27;63(3):323-30. PMID: 23196938. PMCID: PMC3664137
Date: 03/27/2013
HIV acquisition among women from selected areas of the United States: a cohort study
Citation: Hodder SL, Justman J, Hughes JP, Wang J, Haley DF, Adimora AA, Del Rio C, Golin CE, Kuo I, Rompalo A, Soto-Torres L, Mannheimer SB, Johnson-Lewis L, Eshleman SH, El-Sadr WM; HIV Prevention Trials Network 064; Women's HIV SeroIncidence Study Team. HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med. 2013 Jan 1;158(1):10-8. doi: 10.7326/0003-4819-158-1-201301010-00004.
Date: 01/01/2013
Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naïve
Citation: Krishnan S, Schouten JT, Atkinson B, Brown TT, Wohl D, McComsey GA, Glesby MJ, Shikuma C, Haubrich R, Tebas P, Campbell T, Jacobson DL. Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naïve HIV-infected individuals. J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):381-9. PMID: 22828718. PMCID: PMC3480980
Date: 11/01/2012
ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry
Citation: Hochreiter J, Lapham J, Wong-Staal F, McKelvy J, Sulkowski M, Glesby MJ, Johnson VA, Morse GD. ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detection. Antivir Ther. 2013;18(3):329-36. doi: 10.3851/IMP2354. Epub 2012 Sep 6. PMID: 22954720.
Date: 09/06/2012
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized
Citation: Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, Firnhaber C, Grinsztejn B, Hosseinipour MC, Kumwenda J, Lalloo U, Riviere C, Sanchez J, Melo M, Supparatpinyo K, Tripathy S, Martinez AI, Nair A, Walawander A, Moran L, Chen Y, Snowden W, Rooney JF, Uy J, Schooley RT, De Gruttola V, Hakim JG; PEARLS study team of the ACTG. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med. 2012;9(8):e1001290. Epub 2012 Aug 14. PMID: 22936892; PMCID: PMC3419182
Date: 08/14/2012
Dynamics of the resting CD4+ T cell latent HIV reservoir in infants initiating highly active
Citation: Persaud D, Palumbo PE, Ziemniak C, Hughes MD, Alvero CG, Luzuriaga K, Yogev R, Capparelli EV, Chadwick EG. Dynamics of the resting CD4+ T cell latent HIV reservoir in infants initiating highly active antiretroviral therapy less than six months of age. AIDS. 2012 Jul 31;26(12):1483-90. PMID 22555165; PMCID: PMC3495308
Date: 07/31/2012
Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207
Citation: Dooley KE, Park JG, Swindells S, Allen R, Haas DW, Cramer Y, Aweeka F, Wiggins I, Gupta A, Lizak P, Qasba S, van Heeswijk R, Flexner C; ACTG 5267 Study Team. Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267. J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):455-62. doi: 10.1097/QAI.0b013e3182410503. PMID: 22126739. PMCID: PMC3302922.
Date: 04/15/2012
Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T Cell
Citation: Persaud D, Luzuriaga K, Ziemniak C, Muresan P, Greenough T, Fenton T, Blackford A, Ferguson K, Neu N, and Cunningham CK. Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T Cell latent HIV reservoir. AIDS. 2011;28;25(18):2227-34: PMID: 21918423; PMCID: PMC3314338
Date: 11/28/2011
HIV Incidence, risk factors, and motivation for biomedical intervention among gay, bisexual and
Citation: Chariyalertsak S, Kosachunhanan N, Saokhieo P, Songsupa R, Wongthanee A, Chariyalertsak C, Visarutratana S, Beyrer C. HIV Incidence, risk factors, and motivation for biomedical intervention among gay, bisexual and transgender persons in northern Thailand. PLoS One. 2011;6(9):e24295. Epub 2011 Sep 8. PMID: 21931673; PMCID: PMC3169571
Date: 09/08/2011
- ‹ First < 22 23 24 25 26 >